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The replication factors Cdt1 and Cdc6 are essential for ori-
gin licensing, a prerequisite for DNA replication initiation.
Mechanisms to ensure thatmetazoan origins initiate once per
cell cycle include degradation of Cdt1 during S phase and
inhibition of Cdt1 by the geminin protein. Geminin depletion
or overexpression of Cdt1 or Cdc6 in human cells causes
rereplication, a form of endogenous DNA damage. Rereplica-
tion induced by these manipulations is however uneven and
incomplete, suggesting that one or more mechanisms
restrain rereplication once it begins. We find that both Cdt1
and Cdc6 are degraded in geminin-depleted cells. We further
show that Cdt1 degradation in cells that have rereplicated
requires the PCNA binding site of Cdt1 and the Cul4DDB1
ubiquitin ligase, and Cdt1 can induce its own degradation
when overproduced. Cdc6 degradation in geminin-depleted
cells requires Huwe1, the ubiquitin ligase that regulates Cdc6
after DNA damage. Moreover, perturbations that specifically
disrupt Cdt1 and Cdc6 degradation in response to DNA dam-
age exacerbate rereplication when combined with geminin
depletion, and this enhanced rereplication occurs in both
human cells and in Drosophila melanogaster cells. We con-
clude that rereplication-associated DNA damage triggers
Cdt1 and Cdc6 ubiquitination and destruction, and propose
that this pathway represents an evolutionarily conserved
mechanism that minimizes the extent of rereplication.
One of the critical events in the cell division cycle is complete
and precise duplication of the genome. In eukaryotic cells, ori-
gins of DNA replication acquire replication competence
through the assembly of a prereplication complex (preRC)3 in
the G1 phase of the cell cycle. PreRCs are assembled by the
sequential origin binding of the origin recognition complex
(ORC), Cdc6, Cdt1, and the minichromosome maintenance
complex (MCM). Origins harboring preRCs are licensed for
replication but do not initiate DNA synthesis until S phase
begins and the Cdc7 and Cdk2 kinases are activated (1–3). The
large genomes of metazoan cells necessitate the utilization of
thousands of origins, but each origin that initiates DNA synthe-
sis must do so only once. Failure to maintain this control has
been linked to genome instability andoncogenesis (4, 5), but the
cellular consequences of rereplication are not fully understood.
Multiple regulatory mechanisms operate to ensure that any
origins that have “fired” do not fire again by blocking preRC
assembly after the G1 to S phase transition. Among the most
important of thesemechanisms are degradation of Cdt1 during
S phase and inhibition of Cdt1 by the geminin protein. Geminin
depletion, overexpression of Cdt1, or overexpression of Cdc6
causes rereplication, which ultimately triggers a DNA damage
response (6–11) and can promote tumorigenesis (4, 5). Rerep-
lication induced by thesemanipulations is however incomplete,
with the extent of rereplication varying widely among different
cell lines. These observations suggest that in addition to the
mechanisms that block rereplication in the first place, multiple
events restrain rereplication once it begins (10, 12–17).
Previous investigators have noted that human or Drosophila
cells depleted of geminin also become depleted of Cdt1 (14, 18),
but themechanism of that regulation has not been determined.
Moreover, the effects of rereplication on the Cdc6 protein have
not yet been explored. We hypothesized that DNA damage
caused by rereplication is responsible for the observed Cdt1
degradation, and that a similar effect should result in degrada-
tion of Cdc6. In this study we provide evidence that rereplica-
tion-induced degradation of both Cdt1 and Cdc6 requires the
same ubiquitin ligases that regulate Cdt1 and Cdc6 in response
to exogenous DNA-damaging agents. Moreover, Cdt1 overex-
pression stimulates its own degradation by inducing rereplica-
tion-associated DNA damage. We further demonstrate that
disrupting the degradation of either Cdt1 or Cdc6 combined
with geminin depletion exacerbates rereplication. This study
provides evidence for an evolutionarily conserved mechanism,
which destroys essential replication licensing factors once
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rereplication begins as an important means to minimize the
extent of rereplication.
EXPERIMENTAL PROCEDURES
Growth and Manipulation of Cells—HCT116 cells were cul-
tured in McCoy’s 5A medium (Cellgro, Mediatech) supple-
mented with 10% fetal bovine serum (Sigma), and 2 mM gluta-
mine (Invitrogen). NHF1-hTert cells (NHF1) were grown in
Dulbecco’s modified Eagle’s medium (Invitrogen) supple-
mentedwith 10% fetal bovine serum, and 2mMglutamine. Cells
were transfected at a final concentration of 100 nM siRNAusing
Dharmafect Reagent 1 (Dharmacon). siRNA sequences target-
ing geminin (18), DDB1 (19), Huwe1, or green fluorescent pro-
tein (as a control) (20) have been described.Drosophila S2 cells
were grown in F-900 II SFM serum-free medium (Invitrogen)
and treated with 20 g of dsRNA/ml. Primers for generating
dsRNA: cul-1 5-CTGCTCAACGCAGACCG and 5-TGTC-
CTGCAGTTGCTGG, cul-4 5-TTGGCCAAACGATTACT-
TGTGGG and 5-GAGAAGATTATGGCTCAGCG, geminin
5-ATGTCTTCGAGCGCTGCC and 5-GGCGTTGACCTT-
GTCCTCG, Cdt1Dup 5-ACAAACCGCAAACGCGCCG and
5-CCAGCACTGCCTTGAGTTCC, control (pBluescript SK
sequence) 5-ATGGATAAGTTGTCGATCG and 5- ACC-
AGGTTCACATGCTTGCG.
TheHA2-Cdt1 adenovirus has been described (21). C-termi-
nally tagged versions of Cdt1 were constructed by eliminating
the Cdt1 stop codon in pENTR-Cdt1 (21) followed by Clonase
II recombination with pAD/CMV/V5-DEST or pcDNA-
DEST40 according to the manufacturer’s instructions (Invitro-
gen). Cdt1 was truncated after amino acid 321 using a naturally
occurring NcoI site; the PIPm mutation was generated in a
PCR-based strategy. Plasmids were introduced into HCT116
cells by polyethylenimine transfection.
Cell Cycle Analysis—Human cells were collected and pro-
cessed for flow cytometric analysis by ethanol fixation and pro-
pidium iodide staining. Nuclei were analyzed using a CyAn
FACScan (DakoCytomation), and cell cycle distributions were
plotted with Summit v4.3 software (DakoCytomation). Dro-
sophila cells were transfected then plated in concanavalin
A-coated 24-well glass bottom dishes (MatTek) for 1 h prior to
fixation as described (22), stained with DAPI at 5 g/ml, and
scanned with either an IC100 Image Cytometer (Beckman
Coulter) or anArray ScanVTI (Cellomics) equippedwith a 20
0.5NAobjective and anORCA-ER cooledCCDcamera. Images
of 5,000 cells per well were acquired and analyzed using
CytoShop v2.1 (Beckman-Coulter) or vHCS View (Cellomics).
Integrated fluorescence intensity measurements were deter-
mined from unsaturated images. p values were determined
using an unpaired Student’s t test.
Immunoblotting—Anti-Cdt1 is described in Cook et al. (23);
anti-geminin (FL-209), and anti-HA (Y-11) were purchased
from Santa Cruz Biotechnology. Cul4 antibody was raised in
rabbits against the peptide sequence MSAAKKYKPMDTTEL-
HEN (Pocono Farms). Antibodies to p53 phosphorylated at
Ser-15 and Chk2 phosphorylated at Thr-68 were purchased
from Cell Signaling Technologies. Anti-V5 antibody was pur-
chased from Invitrogen. Antibody to Drosophila Cul1 (ZL18)
was purchased fromZymedLaboratories Inc., and antibodies to
both Drosophila and human tubulin were purchased from
Sigma. Cdt1Dup antibody was a gift from T. Orr-Weaver, anti-
Huwe1 was a gift from S. Wing, and anti-DDB1 was a gift from
Y. Xiong. Co-immunoprecipitations were performed essen-
tially as described in Ref. 20, except that whole cell lysates
rather than nuclear lysates were used as the starting material.
RESULTS
Rereplication Induces the Degradation of Cdt1 in Human
Cells—We and others have previously observed that rereplica-
tion induced by RNAi-mediated geminin depletion is incom-
plete. To explore the mechanisms that restrain rereplication in
these cells, we firstmanipulated the expression of both geminin
and Cdt1 in HCT116 colon carcinoma cells and analyzed the
cells by flow cytometry to determine DNA content. Depletion
of geminin by siRNA transfection for 48 h resulted in a popu-
lation of cells with a heterogeneous DNA content greater than
4C, which we defined as cells that had undergone rereplication
(Fig. 1A, left histograms). Rereplication can also be induced by
overproduction of Cdt1 to levels that overwhelm the ability of
geminin to inhibit Cdt1 activity (10). Infecting cells with a
recombinant adenovirus that directs moderate overexpression
of an N-terminally HA-tagged Cdt1 induced rereplication after
24 h, although not as extensively as geminin siRNA transfection
(Fig. 1A, top right histogram). Combining Cdt1 expression with
geminin depletion induced more extensive rereplication than
either single treatment, as determined by the number of cells
with DNA content greater than 4C (Fig. 1A, bottom right histo-
gram). Thus, geminin depletion andCdt1 expression cooperate
to induce rereplication.
Recent evidence suggests that the forks derived from refiring
origins collapse to generate double-strand breaks that can trig-
ger activation of the DNA damage checkpoint (24, 25). As had
been observed by others (12, 13, 26), geminin-depleted cells
acquired molecular markers associated with DNA damage,
including phosphorylation of both p53 and Chk2 (Fig. 1B com-
pare lanes 1 and 3). Cdt1 overproduction also resulted in p53
phosphorylation (Fig. 1B, lane 2). Seemingly paradoxically and
similar to previous observations (14, 18), endogenous Cdt1 lev-
elswere quite low in geminin-depleted cells despite the fact that
Cdt1 is required for replication (Fig. 1B top, compare lanes 1
and 3).
Cdt1 is most abundant in G1 cells, and geminin depletion
results in fewer G1 cells (Fig. 1A). To determine if the down-
regulation of Cdt1 in geminin-depleted cells could be explained
simply by this cell cycle effect, we treated cells with nocodazole
after siRNA transfection to arrest them in G2/prometaphase.
Geminin-depleted G2/M cells rereplicated as before (Fig. 1C),
but also haddramatically lessCdt1 than controlG2/Mcells (Fig.
1D). A similar observation was made in G2-arrested cells by
Ballabeni et al. (18), and the loss of Cdt1 was attributed to ubiq-
uitin-mediated degradation. Geminin binding to Cdt1 may
physically block interaction with a Cdt1 ubiquitin ligase, or
geminin may regulate Cdt1 stability by some replication-inde-
pendentmechanism.An alternative possibilitywe considered is
that the DNA damage induced by rereplication results in Cdt1
degradation.
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Surprisingly, the ectopically expressed N-terminally tagged
HA-Cdt1 protein was largely resistant to degradation in gemi-
nin-depleted cells, whereas the endogenous Cdt1 was readily
degraded (Fig. 1B compare lanes 2 and 4). Persistence of HA-
Cdt1 may have contributed to the increased rereplication we
observed when HA-Cdt1 was expressed in geminin-depleted
cells (Fig. 1A). The resistance of N-terminally tagged Cdt1 to
degradation in geminin-depleted cells suggested that the Cdt1
N terminus is important for regulating Cdt1 stability in rerep-
licating cells. In S phase, Cdt1 ubiquitination and destruction is
mediated by two ubiquitin ligase complexes, Cul1Skp2 and
Cul4DDB1 (27). Cul4DDB1 is also responsible for Cdt1 ubiquiti-
nation in response toDNAdamage (28, 29). Cul1Skp2-mediated
ubiquitination requires phosphorylation of human Cdt1 on
T29, whereas DNA damage-induced ubiquitination of Cdt1
requires Cdt1 binding to PCNA (proliferating cell nuclear anti-
gen), which also binds close to the Cdt1N terminus (27, 30, 31).
We hypothesized that N-terminally tagged Cdt1 was resistant
to degradation in geminin-depleted cells because one or both of
these two ubiquitin ligases could not access Cdt1. To determine
whichmode of Cdt1 degradationwas blocked by theHA tag, we
monitored the stability of HA-Cdt1 as cells progressed through
the cycle or in response to DNA damage. Upon entry into S
phase the HA-Cdt1 protein was degraded at the same cell cycle
point as endogenous Cdt1 (Fig. 1E). The fact that HA-Cdt1 is
sensitive to cell cycle-dependent degradation but not degrada-
tion in geminin-depleted cells (Fig. 1B) further demonstrates
that the Cdt1 degradation in geminin-depleted cells is not due
to a passive cell cycle effect. Unlike endogenous Cdt1, HA-Cdt1
was not degraded in response to ultraviolet (UV) irradiation
(Fig. 1F); a similar observation had been made with N-termi-
nally Myc-tagged Cdt1 in UV-treated cells (30). These results
suggest that the degradation of Cdt1 in geminin-depleted cells
is accomplished by amechanism similar to Cdt1 degradation in
response to DNA damage.
Drosophila Cdt1Dup Is Degraded in Geminin-depleted Cells
through aCul4-dependentMechanism—Todetermine if loss of
Cdt1 in response to rereplication is conserved in other species
we examined the effects of geminin depletion in Drosophila-
melanogaster cells. Transfection of cultured Drosophila S2
cells with dsRNA targeting geminin for 96 h resulted in a dra-
matic increase in the number of cells with greater than 4CDNA
content. In this experiment, DNA content per cell was assessed
by a novel microscopy-based method to measure DAPI-stain-
ing intensity using an IC100 Image Cytometer (Fig. 2A). Gemi-
nin depletion resulted in the degradation of the Cdt1 ortholog
double-parked (Cdt1Dup) as first reported by Mihaylov et al.
(Fig. 2B, lane 3) (14). Todeterminewhich ubiquitin ligasemedi-
ates Cdt1Dup degradation, we co-transfected dsRNA targeting
either Cul1 or Cul4 with the geminin dsRNA. When S2 cells
were depleted of Cul4 and geminin, Cdt1Dup was partially sta-
bilized compared with geminin depletion alone (Fig. 2B, com-
pare lanes 3 and 6). The inability of Cul4 depletion to com-
pletely rescueCdt1Dup levelsmay have been due to the reported
FIGURE 1. Cdt1, but not N-terminally tagged Cdt1, is degraded in gemi-
nin-depleted cells. A, HCT116 cells were transfected with geminin siRNA or a
control sequence for 24 h. Cells were then infected with recombinant adeno-
virus expressing HA-Cdt1 or control virus at a multiplicity of infection (m.o.i.)
of 200 for an additional 24 h. Cells were fixed, stained with propidium iodide,
and analyzed for DNA content by flow cytometry. The percentage of the cell
population harboring DNA content greater than 4C is reported under the
brackets for each plot. B, portions of the cells from A were assayed by immu-
noblotting with the indicated antibodies. Both ectopic and endogenous Cdt1
were detected with anti-Cdt1 antibody; phosphorylation of Chk2 at Thr-68
and p53 at Ser-15 were detected with phosphospecific antibodies. C, HCT116
cells transfected with geminin siRNA for 24 h were treated with 100 ng/l
nocodazole for an additional 24 h to arrest them in prometaphase (G2/M) and
evaluated for DNA content by flow cytometry. D, portions of the cells from C
were assayed by immunoblotting with the indicated antibodies. E, HCT116
cells were infected with recombinant adenovirus as in A. Cells were then
treated with 100 ng/l nocodazole for 18 h to arrest cells at G2/M. Arrested
cells were collected by “mitotic shake-off,” re-plated in nocodazole-free
medium and collected at the indicated times after release. Endogenous
(lower band) and HA-Cdt1 (upper band) were assayed by immunoblotting
with anti-Cdt1 antibody. F, HCT116 cells were infected with recombinant ade-
novirus as in A for 24 h. Cells were then treated with 20 J/m2 UV and collected
at the indicated times post-irradiation and assayed by immunoblotting with
anti-Cdt1 and tubulin antibodies.
FIGURE 2. Geminin depletion in Drosophila S2 cells induces Cul4-depend-
ent Cdt1Dup degradation. A, S2 cells were treated with dsRNA targeting
control sequence or geminin for 4 days. DNA content was determined by
integrated fluorescence intensity of DAPI-stained nuclei. B, S2 cells were
transfected with the indicated dsRNA for 96 h then evaluated for Cdt1Dup,
Cul4, Cul1, and tubulin by immunoblotting.
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down-regulation of Cdt1Dup mRNA in geminin-depleted S2
cells (14). Depletion of Cul1 had little effect onCdt1Dup levels in
geminin-depleted cells (Fig. 2B, compare lanes 3 and 5). Triple
depletion of geminin, Cul1, and Cul4 resulted in Cdt1Dup levels
close to the levels in geminin and Cul4-depleted cells (Fig. 2B,
lane 7), indicating that Cul4 is more important than Cul1 for
regulating Cdt1Dup under these conditions. Interestingly, the
small amount of Cdt1Dup that accumulated in the Cul1-de-
pleted cells had a slower mobility than the Cdt1Dup in Cul4-
depleted cells, suggesting that Cdt1Dupmay have been differen-
tially modified, perhaps by phosphorylation (43).
The Rereplication-associated Degradation of Human Cdt1
Requires the PCNA Binding Site and Cul4DDB1—To determine
if Cul4 is similarly required for degradation of human Cdt1 in
rereplicating cells, we co-transfectedHCT116 cells with siRNA
targeting both geminin and the Cul4 adaptor DDB1. As inDro-
sophila cells depleted of Cul4, depletion of DDB1 prevented the
Cdt1 degradation induced by geminin depletion (Fig. 3A, com-
pare lanes 1 and 2 with lanes 3 and 4). Because Cul4DDB1 is
required for Cdt1 degradation both after DNA damage and
after geminin depletion, and because rereplication induces
DNAdamage, we tested other aspects ofDNAdamage-induced
Cdt1 degradation for similar involvement in Cdt1 degradation
in geminin-depleted cells. DNA damage-induced degradation
of Cdt1 requires an association between the Cdt1 PIP (PCNA-
interacting protein) motif and PCNA. We therefore asked
whether this association is also required for Cdt1 degradation
in geminin-depleted cells. Conserved PIP motif residues at
positions 3, 6, and 9 were altered to alanines (PIPm-Cdt1, Fig.
3B); similar mutations are sufficient to disrupt PCNA binding
and inhibit Cdt1 degradation after UV damage (30, 31) (includ-
ing the single mutation F9A in human Cdt1 (30)). A V5 epitope
tag (or alternatively an RFP tag) was then inserted at the C
terminus of both normal and PIPm-Cdt1. This mutation did
not block the ability of Cdt1 to induce rereplication (Fig. 3C). A
similar PIPm-Cdt1 (31) and even truncation of the first 242
Cdt1 residues (32) complemented Cdt1-depleted Xenopus
laevis extracts for MCM loading and DNA replication, indicat-
ing that PIPm-Cdt1 retains both replication and rereplication-
inducing functions.
To verify that the PIPmmutation blocks Cdt1 degradation in
UV-treated cells, we expressed normal Cdt1 and PIPm-Cdt1 in
HCT116 cells then treated with UV. As expected, wild-type
Cdt1 is readily degraded after UV treatment, but PIPm-Cdt1 is
not (Fig. 3D, compare lanes 3 and 4 with lanes 5 and 6). To test
if the PIP motif is required for Cdt1 degradation in geminin-
depleted cells, WT Cdt1-V5 or PIPm-Cdt1-V5 were expressed
from recombinant adenoviruses in HCT116 cells that had also
been transfected with control or geminin siRNA. Similar to
Cdt1 degradation in UV-treated cells, the PCNA binding site
was required for Cdt1 degradation in cells that had been
induced to rereplicate by geminin depletion (Fig. 3E, compare
lanes 3 and 4 to lanes 5 and 6).
The results described above are consistent with the model in
which rereplication generates DNA damage which then stimu-
lates the PCNA- and Cul4DDB1-dependent ubiquitination and
degradation of Cdt1. An alternative model is that geminin pro-
tects Cdt1 from Cul4DDB1 binding through direct competition,
and in the absence of geminin Cdt1 is more accessible to
Cul4DDB1. To distinguish between degradation of Cdt1 as a
result of rereplication per se and degradation as a consequence
of competition between geminin andCul4 for Cdt1 binding, we
designed an experiment in which rereplication was induced by
overproduction of the N-terminally tagged HA-Cdt1 protein
instead of geminin siRNA transfection (as in Fig. 1), and Cdt1
degradation was monitored by expression of low levels of the
C-terminally taggedCdt1-V5.With increasing amounts ofHA-
Cdt1,WTCdt1-V5 was degraded (Fig. 4A, lanes 2–4), whereas
PIPm-Cdt1-V5 was stable (Fig. 4A, lanes 7–9). To distinguish
whether the excess HA-Cdt1 induced Cdt1-V5 degradation by
inducing rereplication or by sequestering geminin from Cdt1-
V5, we overproduced a form ofHA-Cdt1 truncated after amino
acid 321 (C-HA-Cdt1, Fig. 3B). The corresponding truncation
of the X. laevis Cdt1 fails to load the MCM complex or initiate
replication but retains geminin binding (32). We confirmed
that thismutant fails to induce rereplication (Fig. 4B) but that it
binds geminin equally as well as full-length Cdt1 (Fig. 4C).
HCT116 cells expressing high levels of HA-Cdt1-C failed to
FIGURE 3. Rereplication-induced human Cdt1 degradation requires
DDB1 and the PIP motif of Cdt1. A, HCT116 cells were transfected with
DDB1 siRNA for 72 h and geminin siRNA for 48 h as indicated. Proteins in
whole cell lysates were detected by immunoblotting with the indicated anti-
bodies. B, schematic diagram of full-length Cdt1 and derivatives used in this
study. C, HCT116 cells were infected with adenovirus expressing PIPm
Cdt1-V5 or control virus at an m.o.i of 150. 48 h after infection, cells were
harvested and probed for ectopic Cdt1 with anti-V5 antibody or for rerep-
lication by flow cytometry. D, HCT116 cells were transfected with plasmids
encoding C-terminally RFP-tagged Cdt1, Cdt1-RFP PIPm or control vec-
tors. 24 h after transfection, cells were irradiated as in 1F and collected
30-min post-irradiation. Endogenous and Cdt1-RFP were detected by
immunoblotting with anti-Cdt1 antibody. E, HCT116 cells were infected
with adenovirus expressing WT Cdt1-V5 or PIPm Cdt1-V5 at an m.o.i. of 40
4 h prior to transfection with siRNA targeting geminin or control
sequence. Cells were collected 32 h after transfection and assayed by
immunoblotting with anti-V5, geminin, and tubulin antibodies.
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induce either the degradation of Cdt1-V5 or the phosphoryla-
tion of p53, though it accumulated to similar levels (Fig. 4A,
lanes 5 and 6). These results indicate that it is indeed the rerep-
lication induced by geminin depletion that causes Cdt1
degradation.
Degradation of Cdt1 Limits the Extent of Rereplication—We
hypothesized that the early stages of rereplicationmight gener-
ate sufficient DNA damage to trigger Cdt1 degradation, and
that the loss of Cdt1 would then inhibit further origin relicens-
ing and rereplication. If Cdt1 degradation is an important
mechanism to restrain rereplication, then manipulations that
interfere with Cdt1 degradation are predicted to exacerbate
rereplication. To test that prediction, we infected geminin-de-
pleted HCT116 cells with a moderate dose of the adenoviruses
producing the stabilized PIPm-Cdt1-V5 (as in Fig. 3E). Quan-
tification of the number of cells with greater than 4C DNA
content revealed that PIPm-Cdt1-V5 expression promoted sig-
nificantly more rereplication than normal Cdt1 (WT) did. Nor-
mal Cdt1 was degraded in geminin-depleted cells (Fig. 3E) and
thus had little additive effect on rereplication (Fig. 5A; repre-
sentative histograms are provided as supplemental Fig. S1A).
Furthermore, a similar significant increase in rereplication was
observed when endogenous Cdt1 was stabilized by co-deple-
tion ofDDB1with geminin (Fig. 5B and supplemental Fig. S1B).
While depletion of DDB1 induced a small amount of rereplica-
tion, and this rereplication has been shown to depend on Cdt1
(33), the number of cells that had rereplicated was highest in
cells transfected with both geminin and DDB1 siRNA com-
pared with cells transfected with either siRNA alone (Fig. 5B).
We performed similar rereplication assays to determine if
Cul4-dependent Cdt1Dup degradation also restricts rereplica-
tion in Drosophila S2 cells. Because depletion of the Cul4 pro-
tein takes longer than geminin depletion, S2 cells were treated
withCul4 dsRNA48or 72 hprior to geminin dsRNA treatment.
Cells were harvested at various times after the geminin dsRNA
treatment and analyzed for DNA content as in Fig. 2A. Com-
pared with treatment with geminin dsRNA alone, the combi-
nation of Cul4 and geminin dsRNAs significantly increased the
number of cells that had rereplicated, particularly when the
Cul4 depletion was carried out for 72 h prior to geminin deple-
tion (Fig. 5C and supplemental Fig. S1C). Unlike DDB1 deple-
tion in human cells, Cul4 depletion in Drosophila S2 cells did
not induce rereplication detectable by this assay, perhaps
because Cul4 depletion results in a G1 arrest in S2 cells.4 Taken
4 H. Lee and G. Rogers, unpublished observation.
FIGURE 4. Rereplication-induced Cdt1 degradation is independent of
geminin sequestration. A, HCT116 cells were infected with WT Cdt1-V5,
PIPm Cdt1-V5, or control adenovirus at an m.o.i of 40 and with WT HA-Cdt1 or
C HA-Cdt1 at a m.o.i of 100 () or 300 () for 24 h followed by immunoblot
analysis using the indicated antibodies. B, HCT116 cells were infected with
control, WT HA-Cdt1, or C HA-Cdt1 recombinant adenovirus at an m.o.i of
150. 24 h after infection, cells were harvested and probed for ectopic Cdt1
with anti-HA antibody or for rereplication by flow cytometry. C, HCT116 cells
were infected as in B for 24 h. Cell lysates were probed for ectopic Cdt1 with
anti-HA antibody (top panel) or were subjected to immunoprecipitation with
anti-HA antibody and probed for endogenous geminin (bottom panel).
FIGURE 5. Cdt1 degradation limits the extent of rereplication. A, HCT116
cells depleted of geminin and infected with the indicated adenoviruses
exactly as in Fig. 3E were evaluated for rereplication by flow cytometry as in
Fig. 1A. The percentage of the total population harboring DNA content
greater than 4C is reported. Representative histograms are available as sup-
plemental Fig. S1A. B, HCT116 cells depleted of DDB1 and geminin exactly as
in Fig. 3A were evaluated for rereplication by flow cytometry as in Fig. 1A.
Representative histograms are available as supplemental Fig. S1B. C, Dro-
sophila S2 cells were treated with Cul4 dsRNA every 24 h for either 48 or 72 h
prior to treatment with geminin dsRNA. Samples were collected every 8 h
post-geminin dsRNA treatment. DNA content was measured as in Fig. 2A, and
the percentage of the total population harboring DNA content greater than
4C is reported. Error bars indicate S.D. from three independent experiments.
Representative histograms are available as supplemental Fig. S1C.
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together, these findings suggest that rereplication in geminin-
depleted cells is limited by Cdt1 degradation.
Rereplication-induced Degradation of Cdc6 Requires the
Huwe1 Ubiquitin Ligase—The preceding results demonstrated
that rereplication-induced Cdt1 degradation occurs by the
same mechanism as DNA damage-induced Cdt1 degradation.
The only other component of the preRC that has been shown to
be degraded in response to DNA damage is Cdc6 (20, 34, 35). It
thus seemedpossible that the rereplication-inducedDNAdam-
age could also trigger Cdc6 degradation in geminin-depleted
cells. To test this idea, we monitored the levels of Cdc6 in sev-
eral cell lines transfected with geminin siRNA. Consistent with
the presence of DNA damage as indicated by phosphorylation
of p53 (Fig. 6A), Cdc6 was markedly down-regulated in gemi-
nin-depleted HCT116 cells. We made similar observations in
two other cell lines, HeLa andNHF1 (36). NHF1 cells, likemany
other non-transformed cell lines, did not display an overt rerep-
lication profile by flow cytometry (Fig. 6B and supplemental
Fig. S2A) although geminin depletion was robust and p53 was
phosphorylated (Fig. 6A, compare lanes 5 and 6).
DNA damage-dependent ubiquitination of Cdc6 has been
attributed to two ubiquitin ligases, depending on the cell type
and source of DNAdamage. In p53-proficient cells treatedwith
ionizing radiation, Cdc6 is down-regulated through ubiquitina-
tion by the Cdh1-associated form of the anaphase promoting
complex, APC/C (35). In response to other forms of DNAdam-
age, Cdc6 is ubiquitinated by theHuwe1 enzyme irrespective of
the p53 status of the cells (20). Because we observed Cdc6 deg-
radation after geminin siRNA transfection in a variety of cell
lines, including HeLa cells which have severely compromised
p53 expression, we hypothesized that Huwe1 is required for
Cdc6 degradation in geminin-depleted cells. To test this
hypothesis, we transfected NHF1 cells with siRNA targeting
Huwe1 and geminin either singly or in combination, and then
evaluated those cells for Cdc6 protein levels. As before, geminin
depletion induced a marked down-regulation of Cdc6, but in
cells co-transfected with Huwe1 siRNA, Cdc6 degradation was
prevented (Fig. 6C, compare lanes 2 and 4). Strikingly, the com-
bination of Huwe1 and geminin depletion induced overt rerep-
lication in NHF1 cells whereas neither treatment alone was
sufficient to cause DNA to accumulate to levels greater than 4C
(Fig. 6D).
Rereplication Is Limited after Cdt1 and Cdc6 Degradation—
How can a cell rereplicate when Cdt1 and Cdc6, two proteins
required for replication initiation, have been degraded? Pre-
sumably, the inappropriate relicensing occurred before Cdc6
and Cdt1 were degraded. To test that notion, we transfected
HCT116 cells with siRNA targeting geminin and collected cells
at various times after transfection. Those cells were then eval-
uated for rereplication and the abundance of Cdt1 and Cdc6.
Geminin was maximally depleted by 24 h after siRNA transfec-
tion, but significant degradation of Cdt1 and Cdc6 did not
occur until 40 h after transfection (Fig. 7B). Rereplication was
detectable by flow cytometric analysis beginning at 24-h post-
transfection with the greatest number of cells harboring a DNA
content of greater than 4C peaking at 48 h (Fig. 7A). The initial
checkpoint response to rereplication-associated DNA damage
has been linked to activation of Chk1 (15). In these time
courses, we observed that the activating Ser-317 phosphoryla-
tion of Chk1 coincided with the time when Cdt1 and Cdc6 had
been degraded and the number of rereplicated cells had peaked
and would increase no further (Fig. 7, 40 and 48 h). At the latest
time points, phospho-Chk1 had disappeared either due to sig-
nal quenching or to the induction of apoptosis, which we
observed as a population with sub-G1 DNA content (data not
shown). These results indicate that once rereplication has
begun, Cdc6 and Cdt1 are degraded, and their loss limits the
extent of rereplication even in cells that no longer contain acti-
vated Chk1.
DISCUSSION
In this report we provide evidence that DNA damage that
results from rereplication induces the degradation of bothCdt1
and Cdc6. This phenomenon is conserved in both human and
Drosophila cells with respect to Cdt1 regulation, and perturba-
tions that interfere with DNA damage-dependent degradation
exacerbate rereplication. It is worth noting that the enhanced
rereplication we observed is not likely the result simply of an
initial higher rate of rereplication for two reasons. First, the
stabilizing mutations introduced into Cdt1, the N-terminal
epitope tag and the PIP motif mutant, did not perturb the nor-
mal S phase-dependent degradation of Cdt1, and the overall
abundance of both the normal and DNA damage-resistant
FIGURE 6. Geminin depletion induces Huwe1-dependent Cdc6 degrada-
tion. A, HCT116, HeLa, and NHF1 cells were transfected with geminin siRNA
for 48 h and evaluated by immunoblotting with the indicated antibodies. To
prevent premature mitosis, HeLa cells were treated with nocodazole for 24 h
prior to harvest. B, percentage of cells from A with greater than 4C DNA con-
tent determined by flow cytometry as in Fig. 1A. Representative histograms
are available as supplemental Fig. S2A. C, NHF1 cells were transfected with
Huwe1 siRNA for 24 h then transfected with geminin siRNA for an addi-
tional 48 h. Cell lysates were probed with the indicated antibodies. D, per-
centage of cells from C with greater than 4C DNA content determined by
flow cytometry as in Fig. 1A. Representative histograms are available as
supplemental Fig. S2B.
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forms of Cdt1 were equivalent in the absence of rereplication in
all experiments. Second, stabilization of Cdc6 by Huwe1 deple-
tion does not induce Cdc6 accumulation or rereplication in the
absence of geminin depletion (Fig. 6C and Ref. 20). Thus, the
effects of preventing DNA damage-dependent degradation of
Cdt1 and Cdc6 on the overall extent of rereplication in these
assays are manifest only in the context of rereplication.
Origin relicensing and consequent rereplication can be
induced acutely by transfection with geminin siRNA or with
high levels of ectopically expressedCdt1. These eventsmay also
occur undermore physiological circumstances should cells lose
regulation of Cdt1 or geminin, as is the case for many tumor
cells (37, 38). The ability of Cdt1 to cause rereplication when it
is overproduced combined with the rereplication-induced deg-
radation of Cdt1 indicates that Cdt1-overproducing cells are
actively working to degrade Cdt1 once rereplication begins. In
other words, excess Cdt1 bears the seeds of its own destruction.
As a consequence, rereplication from inappropriately reli-
censed origins prevents additional origin relicensing because
both Cdc6 and Cdt1 are absent (Fig. 7, A and B).
TheDNAdamage that results from rereplication induces not
only Cdt1 and Cdc6 degradation, but also activation of the
ATR-Chk1 checkpoint pathway (10, 12, 13, 16, 26, 39). Recent
studies have shown that components of this DNA damage
checkpoint signaling pathway also play an important role in
restricting the extent of rereplica-
tion when geminin is depleted or
Cdt1 is overproduced (15, 16, 40).
One of the principal outcomes of
checkpoint activation is the inhibi-
tion of cyclin/Cdk activity. The rela-
tionship of Cdk activity to events at
replication origins is complex as
Cdks are not only required for ori-
gin firing but they also act to prevent
new origin licensing after the
G1/S transition by phosphorylating
preRC components (2, 3, 8, 9, 14,
41–43). The accumulation of supra-
physiological DNA contents for a
short time after Chk1 activation and
the onset of Cdc6 and Cdt1 degra-
dation (Fig. 7) could be attributed to
fork elongation from relicensed ori-
gins that had already fired, but we
presume that both origin licensing
and origin firing are already inhib-
ited during that period.
Activation of Chk1 is predicted to
block origin firing by inducing
Cdk inhibition, but this Chk1-
dependent Cdk inhibition would
not prevent origin relicensing. In
fact, inactivation of Cdks in rerepli-
cating cells as a consequence of
DNA damage checkpoint signaling
has the potential to promote even
further origin licensing. To prevent
the relicensing of origins during the period of low Cdk activity,
Cdk-independent mechanisms to block preRC assembly are
required. Degradation of Cdt1 in response to double-strand
breaks induced by ionizing radiation does not require phospho-
rylation by Cdk2 (27, 30) or signaling through the ATM/ATR
checkpoint pathway (29, 44). In that regard, it is important to
note that although Chk1 is phosphorylated as Cdt1 is degraded
(Fig. 7B), checkpoint activation does not itself stimulate Cdt1
degradation; these events are independent of one another.
Huwe1-mediated Cdc6 degradation is similarly unaffected by
Cdk2 phosphorylation (20), though the effects of the check-
point signaling pathway onHuwe1 activity have yet to be deter-
mined. Furthermore, we have previously demonstrated that the
DNA damage-dependent degradation of Cdt1 and Cdc6 are
independent of one another (20). Thus, the degradation of Cdt1
and Cdc6 in rereplicating cells represent two separate mecha-
nisms that block further origin licensing when Cdk activity is
low, and these responses reinforce the checkpoint restraints on
rereplication.
Many laboratories have noted cell line-associated diversity in
the effects of geminin depletion on the final cellular DNA con-
tent. Components of the DNA damage checkpoint pathway are
frequently targets for mutational inactivation or dysregulation
during carcinogenesis, particularly the p53 branch of the path-
way. It has been suggested that differences in the status of this
FIGURE 7. Rereplication is blocked after degradation of Cdt1 and Cdc6. A, HCT116 cells were transfected
with geminin siRNA, harvested at the indicated times following transfection and evaluated by flow cytometry.
The percentage of the population containing DNA content greater than 4C at the indicated time points from
three independent experiments is plotted. B, immunoblot analysis of lysates from a representative experiment
in A. C, model. Rereplication induced by either geminin depletion (or the overproduction of Cdt1 or Cdc6)
results in DNA damage. The DNA damage triggers the ubiquitination of PCNA-bound Cdt1 by Cul4-DDB1 and
ubiquitination of Cdc6 by Huwe1 as well as Chk1 activation. Degradation of Cdt1 and Cdc6 prevents further
rounds of relicensing, and Chk1 activation inhibits origin firing, thus limiting the extent of rereplication.
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checkpoint contribute to the propensity of cells to extensively
rereplicate their DNA (10, 15). We propose that efficient deg-
radation of Cdt1 and Cdc6 to block licensing, combined with
robust DNA damage checkpoint activation to prevent origin
firing, provides an effective restriction of rereplication (Fig. 7C).
The diversity of rereplication phenotypes associated with dif-
ferent cell lines is then a reflection of differences in the genetic
alterations that impact both the checkpoint response and the
efficiency of Cdt1 and Cdc6 degradation. In that regard, one of
the many differences between individual cancers may be the
ability to induce Cdt1 and Cdc6 degradation to limit rereplica-
tion and the genome instability that it promotes.
Acknowledgments—We thank T. Orr-Weaver (Massachusetts Insti-
tute of Technology), Y. Xiong (University of North Carolina at Chapel
Hill, and S. Wing (McGill University) for gifts of antibodies and W.
Kaufmann (University of North Carolina at Chapel Hill) for NHF1-
hTert cells.We thank the laboratory of Steve Rogers for assistancewith
S2 cell imaging.
REFERENCES
1. Sclafani, R. A., and Holzen, T. M. (2007) Annu. Rev. Genet. 41, 237–280
2. Bell, S. P., and Dutta, A. (2002) Annu. Rev. Biochem. 71, 333–374
3. Diffley, J. F. (2004) Curr. Biol. 14, R778–R786
4. Arentson, E., Faloon, P., Seo, J.,Moon, E., Studts, J.M., Fremont, D.H., and
Choi, K. (2002) Oncogene 21, 1150–1158
5. Liontos, M., Koutsami, M., Sideridou,M., Evangelou, K., Kletsas, D., Levy,
B., Kotsinas, A., Nahum,O., Zoumpourlis, V., Kouloukoussa,M., Lygerou,
Z., Taraviras, S., Kittas, C., Bartkova, J., Papavassiliou, A. G., Bartek, J.,
Halazonetis, T. D., and Gorgoulis, V. G. (2007) Cancer Res. 67,
10899–10909
6. Fujita, M. (2006) Cell Div. 1, 22
7. Arias, E. E., and Walter, J. C. (2007) Genes Dev. 21, 497–518
8. Machida, Y. J., Hamlin, J. L., and Dutta, A. (2005) Cell 123, 13–24
9. Blow, J. J., and Dutta, A. (2005) Nat. Rev. Mol. Cell. Biol. 6, 476–486
10. Vaziri, C., Saxena, S., Jeon, Y., Lee, C., Murata, K., Machida, Y., Wagle, N.,
Hwang, D. S., and Dutta, A. (2003)Mol. Cell 11, 997–1008
11. Saxena, S., and Dutta, A. (2005)Mutat. Res. 569, 111–121
12. Melixetian, M., Ballabeni, A., Masiero, L., Gasparini, P., Zamponi, R., Bar-
tek, J., Lukas, J., and Helin, K. (2004) J. Cell Biol. 165, 473–482
13. Zhu, W., Chen, Y., and Dutta, A. (2004)Mol. Cell. Biol. 24, 7140–7150
14. Mihaylov, I. S., Kondo, T., Jones, L., Ryzhikov, S., Tanaka, J., Zheng, J.,
Higa, L. A.,Minamino, N., Cooley, L., and Zhang, H. (2002)Mol. Cell. Biol.
22, 1868–1880
15. Liu, E., Lee, A. Y., Chiba, T., Olson, E., Sun, P., and Wu, X. (2007) J. Cell
Biol. 179, 643–657
16. Lee, A. Y., Liu, E., and Wu, X. (2007) J. Biol. Chem. 282, 32243–32255
17. Tatsumi, Y., Sugimoto, N., Yugawa, T., Narisawa-Saito, M., Kiyono, T.,
and Fujita, M. (2006) J. Cell Sci. 119, 3128–3140
18. Ballabeni, A., Melixetian, M., Zamponi, R., Masiero, L., Marinoni, F., and
Helin, K. (2004) EMBO J. 23, 3122–3132
19. Schrofelbauer, B., Hakata, Y., and Landau, N. R. (2007) Proc. Natl. Acad.
Sci. U. S. A. 104, 4130–4135
20. Hall, J. R., Kow, E., Nevis, K. R., Lu, C. K., Luce, K. S., Zhong, Q., and Cook,
J. G. (2007)Mol. Biol. Cell 18, 3340–3350
21. Braden, W. A., Lenihan, J. M., Lan, Z., Luce, K. S., Zagorski, W., Bosco, E.,
Reed, M. F., Cook, J. G., and Knudsen, E. S. (2006) Mol. Cell. Biol. 26,
7667–7681
22. Rogers, S. L., Rogers, G. C., Sharp, D. J., and Vale, R. D. (2002) J. Cell Biol.
158, 873–884
23. Cook, J. G., Chasse, D. A., and Nevins, J. R. (2004) J. Biol. Chem. 279,
9625–9633
24. Archambault, V., Ikui, A. E., Drapkin, B. J., and Cross, F. R. (2005) Mol.
Cell. Biol. 25, 6707–6721
25. Davidson, I. F., Li, A., and Blow, J. J. (2006)Mol. Cell 24, 433–443
26. McGarry, T. J. (2002)Mol. Biol. Cell 13, 3662–3671
27. Nishitani,H., Sugimoto,N., Roukos, V.,Nakanishi, Y., Saijo,M.,Obuse, C.,
Tsurimoto, T., Nakayama, K. I., Nakayama, K., Fujita, M., Lygerou, Z., and
Nishimoto, T. (2006) EMBO J. 25, 1126–1136
28. Hu, J., McCall, C. M., Ohta, T., and Xiong, Y. (2004) Nat. Cell Biol. 6,
1003–1009
29. Higa, L. A., Mihaylov, I. S., Banks, D. P., Zheng, J., and Zhang, H. (2003)
Nat. Cell Biol. 5, 1008–1015
30. Senga, T., Sivaprasad, U., Zhu,W., Park, J. H., Arias, E. E.,Walter, J. C., and
Dutta, A. (2006) J. Biol. Chem. 281, 6246–6252
31. Arias, E. E., and Walter, J. C. (2006) Nat. Cell Biol. 8, 84–90
32. Ferenbach, A., Li, A., Brito-Martins, M., and Blow, J. J. (2005) Nucleic
Acids Res. 33, 316–324
33. Lovejoy, C. A., Lock, K., Yenamandra, A., and Cortez, D. (2006)Mol. Cell.
Biol. 26, 7977–7990
34. Blanchard, F., Rusiniak,M. E., Sharma, K., Sun, X., Todorov, I., Castellano,
M. M., Gutierrez, C., Baumann, H., and Burhans, W. C. (2002)Mol. Biol.
Cell 13, 1536–1549
35. Duursma, A., and Agami, R. (2005)Mol. Cell. Biol. 25, 6937–6947
36. Heffernan, T. P., Unsal-Kacmaz, K., Heinloth, A. N., Simpson, D. A.,
Paules, R. S., Sancar, A., Cordeiro-Stone, M., and Kaufmann,W. K. (2007)
J. Biol. Chem. 282, 9458–9468
37. Xouri, G., Lygerou, Z., Nishitani, H., Pachnis, V., Nurse, P., and Taraviras,
S. (2004) Eur. J. Biochem. 271, 3368–3378
38. Saxena, S., and Dutta, A. (2003) Cell Cycle 2, 283–286
39. Liu, E., Li, X., Yan, F., Zhao, Q., and Wu, X. (2004) J. Biol. Chem. 279,
17283–17288
40. Lin, J. J., and Dutta, A. (2007) J. Biol. Chem. 282, 30357–30362
41. Hochegger, H., Dejsuphong, D., Sonoda, E., Saberi, A., Rajendra, E., Kirk,
J., Hunt, T., and Takeda, S. (2007) J. Cell Biol. 178, 257–268
42. Nguyen, V. Q., Co, C., and Li, J. J. (2001) Nature 411, 1068–1073
43. Thomer, M., May, N. R., Aggarwal, B. D., Kwok, G., and Calvi, B. R. (2004)
Development 131, 4807–4818
44. Kondo, T., Kobayashi, M., Tanaka, J., Yokoyama, A., Suzuki, S., Kato, N.,
Onozawa, M., Chiba, K., Hashino, S., Imamura, M., Minami, Y., Mi-
namino, N., and Asaka, M. (2004) J. Biol. Chem. 279, 27315–27319
Rereplication-induced Degradation of Cdt1 and Cdc6
SEPTEMBER 12, 2008 • VOLUME 283 • NUMBER 37 JOURNAL OF BIOLOGICAL CHEMISTRY 25363
